Marcaine with Epinephrine .0091 mg/mL

Marcaine with Epinephrine .0091 mg/mL is a local anesthetic injection used for pain relief. This multi-dose solution combines bupivacaine hydrochloride and epinephrine for effective numbing. Ideal for perineural administration, it is manufactured by Hospira, Inc. in the USA.

Marcaine with Epinephrine .0091 mg/mL is primarily used for local anesthesia, providing pain relief during medical procedures. It is often administered perineurally to numb specific areas. This combination of bupivacaine hydrochloride and epinephrine helps extend the duration of the anesthetic effect, making it suitable for various medical applications where prolonged numbness is required.

When administered, Marcaine with Epinephrine .0091 mg/mL typically numbs the targeted area, reducing pain sensations. The addition of epinephrine helps to constrict blood vessels, which can reduce bleeding and prolong the anesthetic effect. Users may experience temporary numbness and a reduction in pain at the injection site.

Marcaine with Epinephrine .0091 mg/mL should be handled with care, ensuring proper sterile techniques are followed during administration. It is important to store the solution as directed to maintain its efficacy. Users should be aware of potential allergic reactions and consult a healthcare provider if any adverse effects occur.

Marcaine with Epinephrine .0091 mg/mL may interact with certain medications, including other anesthetics and blood pressure drugs. It is advisable to inform healthcare providers about all medications being taken to avoid potential interactions. Additionally, the use of epinephrine in this solution may affect individuals with certain heart conditions.